This paper describes the technology and early clinical development of the CAR T NKR-2 platform and elucidates its fundamental differences with classical CAR-T…

Bristol-Myers Squibb

EuroBiotech:​​​ ​​​More​​​ ​​​Articles​​​ ​​​of​​​ ​​​Note

Chutes & Ladders—Bristol-Myers enlists new CSO after major Opdivo setback

Aveo takes baby step forward for once-rejected tivozanib